Lini Imaji Kreasi Ekosistem Tbk. vs Millennium Pharmacon International Tbk. — how do they compare? Lini Imaji Kreasi Ekosistem Tbk. trades at Rp226 (market cap 1.49T, 28.32M 24h volume), while Millennium Pharmacon International Tbk. trades at Rp181 (market cap 230.59B, 12.1K 24h volume). The key difference: Lini Imaji Kreasi Ekosistem Tbk. is far larger — about 6.5× Millennium Pharmacon International Tbk.'s market cap, and Lini Imaji Kreasi Ekosistem Tbk. is more actively traded (28.32M versus 12.1K). Which is the better fit depends on your goals.
| FUTR | SDPC | |
|---|---|---|
Market Cap | 1.49T | 230.59B |
Volume | 28.32M | 12.1K |
Lot | 283.22K | 121 |
Turnover | 6.41B | 2.2M |
Average Price | 226.29 | 181.48 |
Value | 6.41B | 2.2M |
Indicative Equilibrium Price | 226 | — |
Indicative Equilibrium Volume | 4.51K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Lini Imaji Kreasi Ekosistem Tbk (the “Company”) was established under the name of PT LinikiniAspirasi Kreasi based on Notarial Deed No. 74 of Janty Lega, S.H., M.Kn., dated July 29, 2021. The Company started its commercial operations in 2021. The immediate and ultimate parent entities of the Company are PT Digital Futurama Global and PT Investasi Gemilang Maju, respectively.
Read more on FUTR →PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →